ArticleJournal of clinical pharmacology2015

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers.

Jon Tinsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.